Pregled bibliografske jedinice broj: 278314
Novel SSCP Method for Molecular Diagnostics of Thiopurine S-methyltransferase (TPMT) Deficiency
Novel SSCP Method for Molecular Diagnostics of Thiopurine S-methyltransferase (TPMT) Deficiency // Clinical Chemistry and Laboratory Medicine / Siest, Gerard (ur.).
Berlin: Walter de Gruyter, 2004. str. A94-A94 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 278314 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel SSCP Method for Molecular Diagnostics of Thiopurine S-methyltransferase (TPMT) Deficiency
Autori
Štefanović, Mario ; Topić, Elizabeta ; Šimundić, Ana-Maria
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Chemistry and Laboratory Medicine
/ Siest, Gerard - Berlin : Walter de Gruyter, 2004, A94-A94
Skup
International Swiss MedLab 2004 and 8th Alps Adria Congress / Laboratory Medicine: From Atomic absorption to Zeta-Globin
Mjesto i datum
Luzern, Švicarska, 05.10.2004. - 09.10.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Thiopurine S-methyltransferase; Polymorphic drug; Electrophoresisi; Molecular probes
Sažetak
Thiopurine S-methyltransferase (TPMT) is a polymorphic drug metabolizing enzyme which catalyzes inactivation of mercaptopurine, azathioprine and thioguanine. 5– 10% of patients are of intermediate TPMT activity (heterozygous genotype), and about 0.33% have almost no activity at all (homozygous genotype) which leads to excessive drug accumulation with possible severe myelosuppression or even fatal clinical outcome. Few TPMT genotyping methods were developed to date. They include expensive and laborious PCR RFLP or methods that require specific and expensive equipment, not everywhere available (Denaturing HPLC, or Horizontal Conformation Sensitive Gel Electrophoresis). Aim of this study was to design simple PCR-SSCP method for genotyping 5 most common alleles – TPMT*1 (wild type), TPMT*2, TPMT*3A, TPMT*3B and TPMT*3C which comprises for over 90– 95% of TPMT genetic variation. By using the precast GMA (TM) (Gene Mutation Analysis) gels in the SEA 2000 apparatus (Elchrom Scientific, Switzerland), we genotyped 50 DNA samples from healthy subjects previously genotyped by PCR-RFLP. After PCR amplification of three TPMT gene regions containing allele specific point mutations, amplicons were denatured on 95°C, chilled on ice and run overnight under different SSCP electrophoresis conditions (10°C, 15°C and 5°C respectively). Gels were stained with SYBR Gold (Molecular probes, USA). We observed reproducible and uniform band patterns for different TPMT genotypes which were interpreted against positive control samples. Our findings were 100% consistent with samples previously genotyped by PCR RFLP. Among our samples, we found 97.8% TPMT*1 and 2.2% TPMT*3A alleles. Between them, 95.6% were wild type homozygotes and 4.4% TPMT*3A heterozygotes. These results are concordant with other authors' findings. Our conclusion is that this method is reliable and more suitable than previously used PCR-RFLP for identification of known mutations, and it simultaneously screens for new mutations.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Napomena
Dr. sc. Mario Štefanović dobio treću nagradu za najbolji posterski rad.
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE